Oral contraceptives and cardiovascular risk - An end to the debate?

Contraception

Volumn 62, Issue 2 SUPPL. 1, 2000, Pages

  Westhoff, Carolyn L ^a  

^a College of Pysicians and Surgeons of Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESOGESTREL; ESTROGEN; GESTAGEN; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

CARDIOVASCULAR RISK; DRUG SAFETY; EDITORIAL; FEMALE; HEART INFARCTION; HUMAN; ORAL CONTRACEPTION; STROKE; THROMBOEMBOLISM;

CARDIOVASCULAR DISEASES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; RISK FACTORS;

EID: 0033709805     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(00)00150-5     Document Type: Editorial

References (28)

1. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age
2. Investigation of relation between use of oral contraceptives and thromboembolic disease
3. Thromboembolism and oral contraceptives; an epidemiologic case-control study
4. Anovulatory agents and venous disease
5. Thrombophlebitis among oral and non-oral contraceptive users
6. A long-term follow-up study of women using different methods of contraception; an interim report
7. Oral contraceptives and venous thromboembolism; findings in a large prospective study
8. The Walnut Creek contraceptive drug study. A prospective study of the side effects of oral contraceptives, Volume III. An interim report
9. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease
10. The risk of venous thromboembolism associated with low oestrogen oral contraceptives
11. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs
12. Clotting factors during oral contraception; further report
13. Haemostatic, lipid and blood pressure profiles of women on oral contraceptives containing 50 μg or 30 μg oestrogen
14. Risk factors for acute myocardial infarction in women; evidence from the Royal College of General Practitioners' oral contraceptive study
15. Progestogens and arterial disease-Evidence from the Royal College of General Practitioners' study
16. Comparative pharmacology of newer progestogens
17. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
18. Third-generation oral contraceptives and risk of venous thromboembolic disorders; an international case-control study
19. Utilization patterns of oral contraceptives in UK general practice